NCT03573960 2026-03-06
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Phase 4 Completed
Eisai Inc.
Coherus Oncology, Inc.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Zhejiang Provincial People's Hospital